Sciele Home Sciele Products Page Product Development Pipeline Sciele Business Development Sciele Investor Relations Sciele Career Page Sciele Contact Information
 

Glycopyrrolate

Press Releases:

Sciele Pharma Completes Patient Enrollment for Pivotal Phase III Safety Trial for Glycopyrrolate

Sciele Pharma Begins Pivotal Phase III Safety Trial for Glycopyrrolate

Sciele Pharma Receives FDA Orphan Drug Designation for Its Glycopyrrolate to Treat Chronic Drooling in Pediatric Patients

Presentations:

 

Back to Pipeline

Adobe® Reader® is required to view our Prescribing Information documents;
click here to download this free program.

This web site and its contents are intended for use only by residents of the United States. Products discussed may have different labeling, regulatory requirements, and/or medical practices in other countries that may require reference to different or additional information.